Aardvark Therapeutics, Inc. Common Stock (AARD) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.12HealthcareDelayed quote: Oct 6, 2026, 2:28 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — AARD vs OTLK
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)OTLK -64.3% (-40.3%/yr)AARD compounded faster over this window
AARD OTLK
AARD vs OTLK: by the numbers
- •AARD is the larger company ($112M vs $108M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -4416.22% net margin).
Metrics side by side
Valuation
| Metric | AARD | OTLK |
|---|---|---|
| P/B ratio | 1.50 | N/A |
Profitability
| Metric | AARD | OTLK |
|---|---|---|
| Gross margin | 0.00% | 46.49% |
| Operating margin | 0.00% | -4744.25% |
| Net margin | 0.00% | -4416.22% |
| ROE | -93.44% | N/A |
| ROIC | -97.99% | -352.19% |
Growth (annualized)
| Metric | AARD | OTLK |
|---|---|---|
| Total return CAGR (5Y) | N/A | -57.40% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROEOutlook Therapeutics ROEAardvark Therapeutics, Inc. Common Stock operating marginOutlook Therapeutics operating marginAardvark Therapeutics, Inc. Common Stock revenue growthOutlook Therapeutics revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowOutlook Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.